Yanyu Xiao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yanyu Xiao has a total of 138 co-authors. Here are the top co-authors by number of shared publications:
Qineng Ping
State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, PR China
25 shared publications- Sajid Asghar
Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Government College University Faisalabad, Faisalabad 38000, Pakistan
24 shared publications - Zhipeng Chen
School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China
17 shared publications Zhipeng Chen
Department of Pharmacy , Nanjing University of Chinese Medicine , Nanjing 210023 , China
14 shared publicationsSajid Asghar
Ocular Therapeutics Research Group, Pharmaceutical and Molecular Biotechnology Research Centre, Department of Science, South East Technological University, Waterford, Ireland
10 shared publications- Feng Shao
Phase I Clinical Trial Unit, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China
9 shared publications
Latest Publications
- 7 January 2025
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 671, 125191
Design and evaluation of a multi-responsive dual-modality bone-targeted drug delivery vehicle for the treatment of osteosarcoma
- 7 January 2025
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 671, 125191
Design and evaluation of a multi-responsive dual-modality bone-targeted drug delivery vehicle for the treatment of osteosarcoma
- 1 June 2024
- Published by Elsevier in Communications in Nonlinear Science and Numerical Simulation
- Vol. 137, 108097
Dynamical behaviors of a network-based SIR epidemic model with saturated incidence and pulse vaccination
- 1 June 2024
- Published by Elsevier in Communications in Nonlinear Science and Numerical Simulation
- Vol. 137, 108097
Dynamical behaviors of a network-based SIR epidemic model with saturated incidence and pulse vaccination
- Open Access
- 17 November 2022
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 13 (4) , 1498-1521
Recent advances in diverse nanosystems for nitric oxide delivery in cancer therapy
- 17 November 2022
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 13 (4) , 1498-1521
Open AccessRecent advances in diverse nanosystems for nitric oxide delivery in cancer therapy
- 28 June 2022
- Published by Elsevier in Carbohydrate Polymers
- Vol. 294, 119785
Dual-targeted enzyme-sensitive hyaluronic acid nanogels loading paclitaxel for the therapy of breast cancer
- 28 June 2022
- Published by Elsevier in Carbohydrate Polymers
- Vol. 294, 119785
Dual-targeted enzyme-sensitive hyaluronic acid nanogels loading paclitaxel for the therapy of breast cancer
- 15 July 2021
- Published by Taylor & Francis in Expert Opinion on Drug Delivery
- Vol. 18 (10) , 1473-1500
Advances in chlorin-based photodynamic therapy with nanoparticle delivery system for cancer treatment
Introduction: The treatment of tumors is one of the most difficult problems in the medical field at present. Patients often use a comprehensive therapy that combines surgery, radiotherapy, and chemotherapy. Photodynamic therapy (PDT) has prominent potential for eradicating various cancers. Chlorin-based photosensitizers (PSs), as one of the most utilized photosensitizers, have many advantages over conventional photosensitizers; however, a successful chlorin-based PDT needs multi-functional nano-carriers for selective photosensitizer delivery. The number of researches about nanoparticles designed for improved chlorin-based PSs is increasing in the current era. In this article, we give a brief review focused on the recent research progress in design of chlorin-based nanoparticles for the treatment of malignant tumors with photodynamic therapy. Areas covered: This review focuses on the current nanoparticle platforms for PDT, and describes different strategies to achieve controllable PDT by chlorin-nano-delivery systems. The challenges and prospects of PDT in clinical applications are also discussed. Expert opinions: The requirement for PDT to eradicate cancers has increased exponentially in recent years. The major clinically used photosensitizers are hydrophobic. The main obstacles in effective delivery of PSs are associated with this intrinsic nature. The design of nano-delivery systems to load PSs is pivotal for PSs’ widespread use.
- 15 July 2021
- Published by Taylor & Francis in Expert Opinion on Drug Delivery
- Vol. 18 (10) , 1473-1500
Advances in chlorin-based photodynamic therapy with nanoparticle delivery system for cancer treatment
Introduction: The treatment of tumors is one of the most difficult problems in the medical field at present. Patients often use a comprehensive therapy that combines surgery, radiotherapy, and chemotherapy. Photodynamic therapy (PDT) has prominent potential for eradicating various cancers. Chlorin-based photosensitizers (PSs), as one of the most utilized photosensitizers, have many advantages over conventional photosensitizers; however, a successful chlorin-based PDT needs multi-functional nano-carriers for selective photosensitizer delivery. The number of researches about nanoparticles designed for improved chlorin-based PSs is increasing in the current era. In this article, we give a brief review focused on the recent research progress in design of chlorin-based nanoparticles for the treatment of malignant tumors with photodynamic therapy. Areas covered: This review focuses on the current nanoparticle platforms for PDT, and describes different strategies to achieve controllable PDT by chlorin-nano-delivery systems. The challenges and prospects of PDT in clinical applications are also discussed. Expert opinions: The requirement for PDT to eradicate cancers has increased exponentially in recent years. The major clinically used photosensitizers are hydrophobic. The main obstacles in effective delivery of PSs are associated with this intrinsic nature. The design of nano-delivery systems to load PSs is pivotal for PSs’ widespread use.
- 1 July 2021
- Published by Elsevier in Journal of Controlled Release
- Vol. 335, 637-649
Multifunctional nanorods based on self-assembly of biomimetic apolipoprotein E peptide for the treatment of Alzheimer's disease
- 1 July 2021
- Published by Elsevier in Journal of Controlled Release
- Vol. 335, 637-649
Multifunctional nanorods based on self-assembly of biomimetic apolipoprotein E peptide for the treatment of Alzheimer's disease
- 2 March 2021
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 47 (6) , 1-33
Preparation and evaluation of oral self-microemulsifying drug delivery system of Chlorophyll
This study was aimed at improving the water solubility and oral bioavailability of Chl by self-microemulsifying drug delivery system (Chl-SMEDDS).Compatibility experiments, pseudo-ternary phase dia...
- 2 March 2021
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 47 (6) , 1-33
Preparation and evaluation of oral self-microemulsifying drug delivery system of Chlorophyll
This study was aimed at improving the water solubility and oral bioavailability of Chl by self-microemulsifying drug delivery system (Chl-SMEDDS).Compatibility experiments, pseudo-ternary phase dia...
- 1 February 2021
- Published by Elsevier in Carbohydrate Polymers
- Vol. 253, 117194
Lactoferrin/phenylboronic acid-functionalized hyaluronic acid nanogels loading doxorubicin hydrochloride for targeting glioma
- 1 February 2021
- Published by Elsevier in Carbohydrate Polymers
- Vol. 253, 117194
Lactoferrin/phenylboronic acid-functionalized hyaluronic acid nanogels loading doxorubicin hydrochloride for targeting glioma